在女性生殖失败的子宫内膜免疫细胞上明显抑制普雷尼松
Lu Chen1, Xiaoyan Chen1,2, Qianhan Xu1
1Faculty of Medicine, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.
概括
普雷尼松可选择性地减少特定的子宫内膜免疫细胞,如CD3-CD56+CD16-NK细胞和CD68+CD16-巨细胞,在女性生殖功能衰竭. 这种向效应可能会影响不孕症的治疗策略.
科学领域:
- 生殖免疫学 生殖免疫学
- 子宫内膜生物学子宫内膜生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 普雷尼松是一种常见但有争议的治疗方法,用于经历生殖功能衰竭的女性.
- 它对多样化的子宫内膜免疫细胞种群的确切影响尚不清楚.
研究的目的:
- 研究普得尼松对特定子宫内膜免疫细胞亚型的影响.
- 分析在女性生殖功能衰竭前和治疗前和治疗后细胞密度和聚类的变化.
主要方法:
- 从24名植入失败/反复流产 (LH激增+7) 的女性收集了子宫内膜活检.
- 多重染色分析了细胞密度和NK细胞,巨细胞,T细胞和NK-T细胞的聚类.
- 样本在普得尼松注射之前和之后进行了比较.
主要成果:
- 普雷尼松显著降低了CD3-CD56+CD16-NK细胞和CD68+CD16-巨细胞.
- 还观察到这些特定细胞类型的聚类减少.
- 在其他分析的免疫细胞群体中没有发现显著的变化.
结论:
- 普雷尼松表现出选择性免疫抑制,向特定的子宫内膜免疫细胞子集.
- 这些发现表明,普得尼松在生殖失败中的机制可能涉及调节特定的免疫细胞种群,而不是广泛的减少.
相关概念视频
Oogenesis
69.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.0K
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Ovarian Cycle
3.4K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.4K
Hormonal Regulation of the Menstrual Cycle
1.5K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
488
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
488


